Your browser doesn't support javascript.
loading
Stereotactic ablative radiotherapy for the comprehensive treatment of 1-3 Oligometastatic tumors (SABR-COMET-3): study protocol for a randomized phase III trial.
Olson, Robert; Mathews, Lindsay; Liu, Mitchell; Schellenberg, Devin; Mou, Benjamin; Berrang, Tanya; Harrow, Stephen; Correa, Rohann J M; Bhat, Vasudeva; Pai, Howard; Mohamed, Islam; Miller, Stacy; Schneiders, Famke; Laba, Joanna; Wilke, Derek; Senthi, Sashendra; Louie, Alexander V; Swaminath, Anand; Chalmers, Anthony; Gaede, Stewart; Warner, Andrew; de Gruijl, Tanja D; Allan, Alison; Palma, David A.
Afiliación
  • Olson R; Department of Radiation Oncology, BC Cancer - Centre for the North, 1215 Lethbridge Street, Prince George, British Columbia, V2M7E9, Canada. rolson2@bccancer.bc.ca.
  • Mathews L; Department of Radiation Oncology, BC Cancer - Centre for the North, 1215 Lethbridge Street, Prince George, British Columbia, V2M7E9, Canada.
  • Liu M; BC Cancer - Vancouver, Vancouver, British Columbia, Canada.
  • Schellenberg D; BC Cancer - Surrey, Surrey, British Columbia, Canada.
  • Mou B; BC Cancer - Kelowna, British Columbia, Kelowna, Canada.
  • Berrang T; BC Cancer - Victoria, Victoria, British Columbia, Canada.
  • Harrow S; Beatson West of Scotland Cancer Centre, Glasgow, Scotland.
  • Correa RJM; Department of Oncology, London Health Sciences Centre, London, Ontario, Canada.
  • Bhat V; Department of Oncology, London Health Sciences Centre, London, Ontario, Canada.
  • Pai H; BC Cancer - Victoria, Victoria, British Columbia, Canada.
  • Mohamed I; BC Cancer - Kelowna, British Columbia, Kelowna, Canada.
  • Miller S; Department of Radiation Oncology, BC Cancer - Centre for the North, 1215 Lethbridge Street, Prince George, British Columbia, V2M7E9, Canada.
  • Schneiders F; Department of Radiation Oncology, Amsterdam University Medical Centre (UMC), Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Laba J; Department of Oncology, London Health Sciences Centre, London, Ontario, Canada.
  • Wilke D; Nova Scotia Cancer Centre, Halifax, Nova Scotia, Canada.
  • Senthi S; Alfred Health Radiation Oncology, Melbourne, Australia.
  • Louie AV; Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
  • Swaminath A; Department of Radiation Oncology, Amsterdam University Medical Centre (UMC), Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Chalmers A; University of Glasgow, Glasgow, Scotland.
  • Gaede S; Department of Oncology, London Health Sciences Centre, London, Ontario, Canada.
  • Warner A; BC Cancer - Surrey, Surrey, British Columbia, Canada.
  • de Gruijl TD; Department of Oncology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands.
  • Allan A; Department of Oncology, London Health Sciences Centre, London, Ontario, Canada.
  • Palma DA; Department of Oncology, London Health Sciences Centre, London, Ontario, Canada.
BMC Cancer ; 20(1): 380, 2020 May 05.
Article en En | MEDLINE | ID: mdl-32370765

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Radiocirugia / Selección de Paciente / Tomografía Computarizada Cuatridimensional / Células Neoplásicas Circulantes / Neoplasias Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Canadá

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Radiocirugia / Selección de Paciente / Tomografía Computarizada Cuatridimensional / Células Neoplásicas Circulantes / Neoplasias Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Canadá